Paid Clinical Trials in Colorado

Login to your account

Reset Password

Please Enter Username or Email

Create a free account

I'm a Participant
I'm an Organization

Showing 21 – 40 of 378 results

Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)

by CTG

in Prostate Cancer

Other

Colorado

Deadline:

12/01/2026

A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer

by CTG

in Advanced Prostate Cancer

Other

Colorado

Deadline:

10/27/2027

A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies

by CTG

in Advanced Cancer

Other

Colorado

Deadline:

11/01/2026

A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies

by CTG

in Advanced Cancer

Other

Colorado

Deadline:

11/01/2026

Long Term Evaluation of Scapular-inserted Contraceptive Implants

by CTG

in Contraception

Other

Colorado

Deadline:

10/01/2027

Registry of Asthma Characterization and Recruitment 3 (RACR3)

by CTG

in Asthma

Other

Colorado

Deadline:

05/01/2028

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

by CTG

in Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)

Other

Colorado

Deadline:

12/30/2030

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

by CTG

in Mantle Cell Lymphoma, Lymphoma, Non-Hodgkin, Large B-cell Lymphoma, B-cell Acute Lymphoblastic Leukemia, Indolent Lymphoma

Other

Colorado

Deadline:

12/01/2038

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

by CTG

in Waldenstrom Macroglobulinemia

Other

Colorado

Deadline:

12/01/2027

Incidence & Clinical Significance of Osteolysis Following PEEK Suture Anchor Use in Hand & Wrist Surgery

by CTG

in Osteolysis

Other

Colorado

Deadline:

12/10/2026

Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML

by CTG

in Acute Myeloid Leukemia

Other

Colorado

Deadline:

10/01/2026

Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.

by CTG

in ER+ HER2- Advanced Breast Cancer

Other

Colorado

Deadline:

06/24/2027

The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis

by CTG

in Inflammatory Bowel Diseases (IBD), Ankylosing Spondylitis (AS)

Other

Colorado

Deadline:

10/01/2026

Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study

by CTG

in Type 2 Diabetes, Obesity, Diabetic Nephropathies, Diabetes Type 2, Nephropathy

Other

Colorado

Deadline:

05/01/2029

CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML or HR-MDS

by CTG

in Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS), Relapsed Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)/AML

Other

Colorado

Deadline:

12/01/2029

Quantitative and Clinical Assessment of Flexor Tendon Gliding Following Application of a Bioresorbable Hydrogel: A Prospective, Randomized Study in Patients Undergoing Distal Radius Fracture Repair

by CTG

in Distal Radius Fracture, Tendon Rupture

Other

Colorado

Deadline:

07/01/2027

4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity

by CTG

in Breast Cancer

Other

Colorado

Deadline:

06/01/2027

MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus

by CTG

in Diabetes Mellitus, Type 1, Autoimmune Diabetes, Type1 Diabetes Mellitus, Juvenile Diabetes, Diabetes Mellitus Complication

Other

Colorado

Deadline:

08/01/2026

A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

by CTG

in Multiple Myeloma

Other

Colorado

Deadline:

01/01/2036

A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases

by CTG

in Eosinophilic Granulomatosis With Polyangiitis (EGPA)

Other

Colorado

Deadline:

04/03/2028

Load more All clinical trials loaded.